<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01058694</url>
  </required_header>
  <id_info>
    <org_study_id>2008-005</org_study_id>
    <nct_id>NCT01058694</nct_id>
  </id_info>
  <brief_title>The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya</brief_title>
  <acronym>CAPS</acronym>
  <official_title>Adherence to ARV Treatment and Its Effects on Medium Run Socio-Economic Outcomes: Evidence From Western Kenya</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Moi Univeristy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Bank</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of proposed research is to implement a randomized study that will allow us to
      understand and address a number of key barriers to patient adherence as well as study the
      effects of better adherence on health and socio-economic outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown that proper adherence to treatment regimens is essential for the
      effectiveness of ARV therapy (e.g Wools-Kaloustian et al. 2006). There is also evidence in
      that in some treatment programs in Africa, adherence rates are not always high (Gill et al.
      2005). Even in settings where adherence levels are found to be high, numerous factors have
      been identified as being relevant, although the causal effects are unknown (Castro, 2006). As
      ARV treatment programs are scaled up in Africa, it is essential to understand the
      socio-economic determinants of adherence to ARV treatment, as well as the impact of
      interventions to support high levels of adherence. A secondary objective of this study is to
      understand the socio-economic impacts of higher adherence.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MEMS Adherence</measure>
    <time_frame>12 months follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency/incidence of ARV treatment interruptions</measure>
    <time_frame>12 months follow up</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">720</enrollment>
  <condition>AIDS</condition>
  <condition>Antiretroviral Therapy</condition>
  <condition>Medication Adherence</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Weekly SMS, brief message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weekly SMS received on Monday at 12 noon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receives a phone, but no messages.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Daily SMS, Brief message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive daily brief message at 12 noon: &quot;This is your reminder&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Daily SMS, Long Message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive a daily long message at 12 noon: &quot;This is your reminder + encouragement&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekly SMS, Long Message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weekly message sent at 12 noon on Mondays: &quot;This is your reminder + encouragement&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Short Message Services to Support ARV therapy adherence</intervention_name>
    <description>Short message services were sent to randomly selected consenting subjects on ARV therapy. The frequency and content of the message is varied in a factorial design.</description>
    <arm_group_label>Weekly SMS, brief message</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Daily SMS, Brief message</arm_group_label>
    <arm_group_label>Daily SMS, Long Message</arm_group_label>
    <arm_group_label>Weekly SMS, Long Message</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who had been on ARV therapy at the Chulaimbo Rural Health Center for a
             maximum of three months and providing consent to participate in the study.

        Exclusion Criteria:

          -  Patients who had been on ARV therapy for more than 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Sidle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Duncan Ngare, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harsha Thirumurthy, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Goldstein, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>World Bank</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joshua Graff-Zivin, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Damien de Walque, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>World Bank</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristian Pop-Eleches, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Bangsberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chulaimbo Rural Health Center</name>
      <address>
        <city>Kisumu</city>
        <state>Maseno District</state>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2010</study_first_submitted>
  <study_first_submitted_qc>January 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2010</study_first_posted>
  <last_update_submitted>January 28, 2010</last_update_submitted>
  <last_update_submitted_qc>January 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>James Habyarimana, PhD/Assistant Professor</name_title>
    <organization>Georgetown Public Policy Institute</organization>
  </responsible_party>
  <keyword>Mobile phones,</keyword>
  <keyword>Medication Adherence</keyword>
  <keyword>Micro-Electrical-Mechanical Systems</keyword>
  <keyword>HIV Infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

